1. An early Phase I study to determine the tolerance, safety and pharmacokinetics of idebenone following multiple oral doses;Barkworth;Arzneim. Forsch.,1985
2. Report on pharmacokinetics of CV-2619 and Two Metabolites Following Multiple Dosing in Elderly Patients with Mild Dementia;Bradbrook,1986
3. Clinical study of CV-2619 (idebenone) in cerebral vascular disease;Iyoda;Jap. Pharm. Ther.,1985
4. Usefulness of CV-2619 tablets for cerebrovascular disorders and senile dementia in a broad sense;Matsubara;Ther. Res.,1985